These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 22447803)
1. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong. Tung CK; Chiang TP; Lam M East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803 [TBL] [Abstract][Full Text] [Related]
3. Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Every-Palmer S Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162 [TBL] [Abstract][Full Text] [Related]
4. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure. Gudsoorkar VS; Perez JA Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029 [TBL] [Abstract][Full Text] [Related]
5. Psychosis and synthetic cannabinoids. Deng H; Verrico CD; Kosten TR; Nielsen DA Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871 [TBL] [Abstract][Full Text] [Related]
6. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report. Durand D; Delgado LL; de la Parra-Pellot DM; Nichols-Vinueza D Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):205-8. PubMed ID: 23518784 [TBL] [Abstract][Full Text] [Related]
8. Myocardial infarction associated with use of the synthetic cannabinoid K2. Mir A; Obafemi A; Young A; Kane C Pediatrics; 2011 Dec; 128(6):e1622-7. PubMed ID: 22065271 [TBL] [Abstract][Full Text] [Related]
9. The Changing Drug Culture: Emerging Drugs of Abuse and Legal Highs. Albertson TE; Chenoweth JA; Colby DK; Sutter ME FP Essent; 2016 Feb; 441():18-24. PubMed ID: 26881769 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacological properties and dependence liabilities of synthetic cannabinoids]. Funada M Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Jun; 45(3):167-74. PubMed ID: 20681249 [TBL] [Abstract][Full Text] [Related]
11. Spice/K2 drugs--more than innocent substitutes for marijuana. Zawilska JB; Wojcieszak J Int J Neuropsychopharmacol; 2014 Mar; 17(3):509-25. PubMed ID: 24169044 [TBL] [Abstract][Full Text] [Related]
12. Mephentermine dependence syndrome - A new emerging trend of substance use. Gowda GS; Singh A; Ravi M; Math SB Asian J Psychiatr; 2015 Oct; 17():101-2. PubMed ID: 26236018 [No Abstract] [Full Text] [Related]
13. Risky recreation: synthetic cannabinoids have dangerous effects. McGuinness TM; Newell D J Psychosoc Nurs Ment Health Serv; 2012 Aug; 50(8):16-8. PubMed ID: 22801822 [TBL] [Abstract][Full Text] [Related]
14. Toxicological findings of synthetic cannabinoids in recreational users. Kronstrand R; Roman M; Andersson M; Eklund A J Anal Toxicol; 2013 Oct; 37(8):534-41. PubMed ID: 23970540 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Spiller HA; Ryan ML; Weston RG; Jansen J Clin Toxicol (Phila); 2011 Jul; 49(6):499-505. PubMed ID: 21824061 [TBL] [Abstract][Full Text] [Related]
16. [Synthetic drugs: the new low-cost landscape of drugs]. Karila L; Petit A; Cottencin O; Coscas S; Reynaud M Rev Prat; 2012 May; 62(5):664-6. PubMed ID: 22730798 [TBL] [Abstract][Full Text] [Related]
17. Psychoactive drug abuse in older adults. Simoni-Wastila L; Yang HK Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542 [TBL] [Abstract][Full Text] [Related]
19. New drugs of abuse in North America. Haroz R; Greenberg MI Clin Lab Med; 2006 Mar; 26(1):147-64, ix. PubMed ID: 16567229 [TBL] [Abstract][Full Text] [Related]
20. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg? Di Forti M; Morrison PD; Butt A; Murray RM Curr Opin Psychiatry; 2007 May; 20(3):228-34. PubMed ID: 17415074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]